Connect with us

Hi, what are you looking for?


Aboitiz Group’s contribution to government coronavirus response efforts reaches P2.2B

THE ABOITIZ GROUP’S contribution to the country’s coronavirus disease 2019 (COVID-19) response has reached over P2.2 billion, with the company being among the firms that first offered support to the government at the beginning of the pandemic.

The Aboitiz Group said in a statement that its total contribution to the national COVID-19 response has reached over P2.2 billion as of Sunday.

“The Aboitiz Group believes that a strong collaboration between the public and private sectors is critical to our battle against COVID-19. Through these vaccines, we will be able to help ensure people are safe and protected from the virus while keeping our economy moving,” Aboitiz Group President and Chief Executive Officer Sabin M. Aboitiz said.

“The Aboitiz Group was among the first conglomerates to extend help and support to the government at the start of the pandemic, especially for Cebu and Davao City,” Presidential Peace adviser and the former general in charge of the strategy to combat COVID-19 Carlito G. Galvez, Jr. said.

Expressing his gratitude to the company, Mr. Galvez said the virus response required “close cooperation” between the public and private sectors.

The Aboitiz Group was one of the companies that inked a tripartite agreement in a virtual event last Friday to collaborate with the government and UK-based drugmaker AstraZeneca Plc to provide 2.6 million COVID-19 vaccine doses to Filipinos.

The procured vaccines will be deployed by the Department of Health and administered to government frontline workers and private-sector employees. Two doses of the vaccine are expected to cost around P500 or $10.

Presidential Adviser for Entrepreneurship and Go Negosyo founder Joey A. Concepcion, who was present during the tripartite agreement signing, said that he expected the vaccines to arrive by May or June next year.

Meanwhile, AstraZeneca Pharmaceuticals Philippines, Inc. president Lotis Ramin said the firm is “working closely with regulatory authorities across the globe in bringing solutions to end the pandemic.” — A.Y. Yang

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



By Diego Gabriel C. Robles THE Philippine economy expanded by 7.4% in the second quarter — slower than expected — as rising inflation weighed...


By Abigail Marie P. Yraola, Researcher THE Philippines’ merchandise trade deficit hit another record in June as imports continued to outpace exports despite a...


THE National Government’s (NG) outstanding debt as a share of the gross domestic product (GDP) eased to 62.1% at the end of June. Data...


By Keisha B. Ta-asan SOURED LOANS held by Philippine banks fell for a fourth straight month in June, bringing the nonperforming loan (NPL) ratio...


Smart says third telco player’s PCC complaint meant to avoid liability By Arjay L. Balinbin, Senior Reporter GLOBE Telecom, Inc. on Tuesday said it...


DMCI Holdings, Inc. reported on Tuesday that its second-quarter consolidated net income went up by 73% to P9.03 billion from P5.23 billion, driven by...

You May Also Like


Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...


Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...


Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...


Instagram still holds the top spot for social media in terms of building brand reputation and expanding business potential. Every day, more and more...

Disclaimer:, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.